Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to ...

Discover Axsome Therapeutics (NASDAQ:AXSM), a pioneering biopharmaceutical company dedicated to creating innovative ...

Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Genmab (GMAB – Research Report), with a price target of $25.00. The company’s shares ...

Annual Financial Report. PR Newswire. LONDON, United Kingdom, June 04. The Biotech Growth Trust PLC (the Company) Annual Results for the Year Ended ...

Fintel reports that on June 3, 2025, Oppenheimer initiated coverage of Axsome Therapeutics (NasdaqGM:AXSM) with a Outperform ...

Purohit’s continued optimism is primarily driven by the strong commercial performance of Auvelity, the company’s treatment ...

Discover who owns Axsome Therapeutics Inc, including major AXSM shareholders and institutional investors. Investing.com - Financial Markets Worldwide Open in App ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX – Research Report) and Axsome Therapeutics (AXSM – Rese ...

Tilray Brands, Inc. ("Tilray") , a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that Irwin D. Simon, ...

The Health Industry Series - ASEAN (tHIS ASEAN 2025), a groundbreaking event aimed at integrating healthcare resources across Southeast Asia, is set to take place in Kuala Lumpur during June 9-11.